BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26159742)

  • 1. Drug interactions of hepatitis C direct-acting antivirals in the HIV-infected person.
    El-Sherif O; Back D
    Curr HIV/AIDS Rep; 2015 Sep; 12(3):336-43. PubMed ID: 26159742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic HCV genotype 1 coinfection.
    Boesecke C; Rockstroh JK
    Curr HIV/AIDS Rep; 2015 Sep; 12(3):326-35. PubMed ID: 26228050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of acute and chronic HCV infection in persons with HIV coinfection.
    Sulkowski MS
    J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions.
    Chan J; Chung RT
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):147-163. PubMed ID: 28263458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.
    Rockstroh JK
    Liver Int; 2015 Jan; 35 Suppl 1():51-5. PubMed ID: 25529087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment options for hepatitis C patients co-infected with HIV.
    Rockstroh JK; Hardy WD
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):689-95. PubMed ID: 26799571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.
    Esposito I; Labarga P; Barreiro P; Fernandez-Montero JV; de Mendoza C; Benítez-Gutiérrez L; Peña JM; Soriano V
    Expert Opin Drug Saf; 2015; 14(9):1421-34. PubMed ID: 26212044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals.
    Cope R; Pickering A; Glowa T; Faulds S; Veldkamp P; Prasad R
    AIDS Patient Care STDS; 2015 Jul; 29(7):379-83. PubMed ID: 26066094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?
    Bruno G; Saracino A
    Curr HIV Res; 2017; 15(6):422-433. PubMed ID: 29119934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simeprevir for the treatment of hepatitis C and HIV/hepatitis C co-infection.
    Flanagan S; Crawford-Jones A; Orkin C
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):691-704. PubMed ID: 25209158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.
    Smolders EJ; Smit C; de Kanter C; Dofferhoff A; Arends JE; Brinkman K; Rijnders B; van der Valk M; Reiss P; Burger DM;
    HIV Med; 2018 Mar; 19(3):216-226. PubMed ID: 29194939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hepatitis C: the use of the new pangenotypic direct-acting antivirals in "special populations".
    Pol S; Parlati L
    Liver Int; 2018 Feb; 38 Suppl 1():28-33. PubMed ID: 29427485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interactions in HIV-infected patients treated for hepatitis C.
    Soriano V; Labarga P; Fernandez-Montero JV; Mendoza C; Benítez-Gutiérrez L; Peña JM; Barreiro P
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):807-816. PubMed ID: 28689442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
    Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
    AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key drug-drug interactions with direct-acting antiviral in HIV-HCV coinfection.
    El-Sherif O; Khoo S; Solas C
    Curr Opin HIV AIDS; 2015 Sep; 10(5):348-54. PubMed ID: 26248122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.
    Martinello M; Hajarizadeh B; Grebely J; Dore GJ; Matthews GV
    Curr HIV/AIDS Rep; 2017 Jun; 14(3):110-121. PubMed ID: 28432579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms.
    Cooper CL; Klein MB
    HIV Med; 2014 Nov; 15(10):621-4. PubMed ID: 24802099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral drugs and the treatment of hepatitis C.
    Jalali Z; Rockstroh JK
    Curr HIV/AIDS Rep; 2012 Jun; 9(2):132-8. PubMed ID: 22354528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects.
    Hlavay BA; Zhuo R; Ogando N; Charlton C; Stapleton JT; Klein MB; Power C
    J Clin Virol; 2023 May; 162():105445. PubMed ID: 37043902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.
    Yaya I; Roux P; Marcellin F; Wittkop L; Esterle L; Spire B; Dominguez S; Elegbe BA; Piroth L; Sogni P; Salmon-Ceron D; Carrieri MP;
    PLoS One; 2018; 13(7):e0199874. PubMed ID: 29975764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.